No.

 Title

Application number

Authority

Application date

Status

LNT001

 Bacteriophage of Pseudomonas aeruginosa and uses thereof

10-1382893

KR

2014.04.01

granted

LNT002

 Bacteriophage of Salmonella enterica and uses thereof

10-1449417

KR

2014.10.02

granted

LNT003

 Composition for infecting bacteria resistant to bacteriophage infection comprising bacteriophage PBECO4 or CEA derived therefrom and its use

10-1607395

KR

2016.03.23

granted

LNT004

 Bacteriophage PA7 of Pseudomonas aeruginosa

10-1612607

KR

2016.04.07

granted

LNT005

 Composition and method of increasing production of bacteriophage by use of Reactive oxygen species

10-1909831

KR

2018.10.12

granted

LNT006

 Bacteriophage of Klebsiella pneumoniae and uses thereof

10-2019-0022686

KR

2019.02.26

applied

LNT007

 Oncolytic T7 bacteriophage having cytokine gene and displaying homing peptide on capsid and its use for treating cancer

10-2209906

KR

2021.01.26

granted

LNT008

 Bacteriophage of Pseudomonas aeruginosa and uses thereof

10-2019-0117450

KR

2019.09.24

applied

LNT009

 Oncolytic T7 bacteriophage having cytokine gene and displaying homing peptide on capsid and its use for treating cancer

US 16/685,516

US

2019.11.15

applied

LNT010

 Composition and method of increasing production of bacteriophage, using reactive oxygen species

US 16/642,599

US

2020.02.27

applied

LNT011

 Composition and method of increasing production of bacteriophage, using reactive oxygen species 

EP 18851987.0

EPO

2020.03.17

applied

LNT012

 Novel Polypeptide and Antibiotics against Enterococcus spp. Bacteria Comprising the Polypeptide

10-2224896

KR

2021.03.02 

granted

LNT013

 Novel Polypeptide and Antibiotics against Gram-Negative Bacteria Comprising the Polypeptide

10-2224897

KR

2021.03.02

granted

LNT014

 Polypeptide Variants and Antibiotics against Gram-Negative Bacteria Comprising the Same

10-2228999

KR

2021.03.11

granted

LNT015

 Fusion Polypeptides and Antibiotics against Gram-Negative Bacteria Comprising the Same 

10-2286544

KR

2021.07.30

granted 

LNT016

 Novel polypeptide, Fusion polypeptide, and Antibiotic against Gram-negative bacteria comprising the same

 PCT/KR2021/006302

 PCT 

2021.05.20 

applied 

 LNT017 

 Novel Polypeptide and Antibiotics against Gram-Negative Bacteria Comprising the polypeptide 

10-2021-0199266 

 KR 

2021.08.19

applied 

LNT018

 Polypeptides, Fusion proteins, and Uses Thereof 

10-2022-0012566 

 KR 

 2022.01.27 

applied